Background and objectives: Lung volume reduction surgery (LVRS) improv
es ventilatory function in selected patients with severe COPD. The rea
sons for the observed benefits include the following: increased elasti
c recoil, improved airflow, and lesser dynamic hyperinflation and decr
eased lung volumes. We reasoned that these changes could also alter re
spiratory drive. Methods: Respiratory central drive was prospectively
assessed using the month occlusion pressure (P-0.1), and the P-0.1 res
ponse to increasing CO2 (P-0.1/PETCO2 [end-tidal CO2 pressure]), in ei
ght sequential patients before and 3 to 5 months after LVRS. Results w
ere compared with those from 13 control subjects.Results: LVRS decreas
ed total lung capacity from 7.44+/-1.8 L to 5.92+/-1.3 L (p<0.05) and
residual volume from 4.97+/-1.5 L to 3.56+/-1.1 L (p<0.05). It also si
gnificantly improved FEV1 from 0.85+/-0.26 L 0.99+/-0.26 L (p<0.05). B
aseline P-0.1 (3.4+/-1.8 vs 1.4+/-0.4 cm H2O, p<0.01) and P-0.1/PETCO2
(0.24+/-0.07 vs 0.11+/-0.04 cm H2O/mm Hg, p<0.05) were higher in pati
ents than in control subjects. After LVRS, P-0.1 decreased from 3.4+/-
1.8 to 1.3+/-0.75 cm H2O (p<0.01) and P-0.1/PETCO2 from 0.24+/-0.07 to
0.16+/-0.06 cm H2O/mm Hg (p<0.05). These postoperative values were si
milar to those of control subjects. There were no correlations between
changes in the factors known to influence central drive (PaO2, PaCO2,
age, weight, height, FVC, and FEV1) and changes in P-0.1. Conclusions
: We conclude that decreased ventilatory drive should be added to the
list of benefits of LVRS, and may help explain the symptomatic improve
ment reported by many patients after this surgery.